These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 26883263)

  • 1. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF; Tang H; Guo H; Pan WS
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of poly(ethylene oxide) in controlled release tablet systems: a review.
    Ma L; Deng L; Chen J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):845-51. PubMed ID: 24001212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero-Order Controlled Delivery of Gliclazide from Polyethylene Oxides Matrix Tables: In vitro and In vivo Evaluation.
    Wang L; Yang X; Di Y; Chen K; Wen H; Pan W
    Curr Drug Deliv; 2017; 14(1):136-144. PubMed ID: 27000027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
    Wen H; Li X; Li Y; Wang H; Wang Y; Wang T; Pan W; Yang X
    Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study.
    Maggi L; Segale L; Torre ML; Ochoa ME; Conte U
    Biomaterials; 2002 Feb; 23(4):1113-9. PubMed ID: 11791914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration.
    Vanza JD; Patel RB; Dave RR; Patel MR
    Pharm Dev Technol; 2020 Dec; 25(10):1169-1187. PubMed ID: 32772604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel bilayer gastroretentive tablets based on hydrophobic polymers.
    Nguyen TT; Hwang KM; Kim SH; Park ES
    Int J Pharm; 2020 Jan; 574():118865. PubMed ID: 31765783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
    Turner S; Federici C; Hite M; Fassihi R
    Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical factors in the release of drugs from sustained release hydrophilic matrices.
    Maderuelo C; Zarzuelo A; Lanao JM
    J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Larsson A
    J Pharm Sci; 2011 Jan; 100(1):275-83. PubMed ID: 20572053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical moments in modelling of swelling, erosion and drug release of hydrophilic matrix-tablets.
    Barmpalexis P; Kachrimanis K; Malamataris S
    Int J Pharm; 2018 Apr; 540(1-2):1-10. PubMed ID: 29407874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico mechanistic disposition and in vivo evaluation of zero-order drug release from a novel triple-layered tablet matrix.
    Moodley K; Choonara YE; Kumar P; du Toit LC; Pillay V
    Expert Opin Drug Deliv; 2015 May; 12(5):693-713. PubMed ID: 25534542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
    Ferrero C; Massuelle D; Doelker E
    J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.